Vanguard Group Inc Viatris Inc Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Viatris Inc stock. As of the latest transaction made, Vanguard Group Inc holds 140,273,202 shares of VTRS stock, worth $1.5 Billion. This represents 0.02% of its overall portfolio holdings.
Number of Shares
140,273,202
Previous 145,115,010
3.34%
Holding current value
$1.5 Billion
Previous $1.3 Billion
7.16%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
966MCall Options Held
7.74MPut Options Held
2.47M-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX37.4MShares$401 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...